Syndromes Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Syndromes stocks.

Syndromes Stocks Recent News

Date Stock Title
Nov 1 ALXO ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with Zanidatamab will be Presented at the San Antonio Breast Cancer Symposium (SABCS) 2024
Nov 1 REGN What Makes Regeneron Pharmaceuticals (REGN) an Attractive Investment Opportunity?
Nov 1 REGN Regeneron Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
Nov 1 REGN Regeneron: Investors In Panic Mode On Increased Eylea Fears
Nov 1 REGN Regeneron battles Wall Street uncertainty; Madrigal extends fast launch of MASH drug
Nov 1 REGN Regeneron Pharmaceuticals Inc (REGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth ...
Nov 1 REGN Q3 2024 Regeneron Pharmaceuticals Inc Earnings Call
Oct 31 REGN Regeneron Pharmaceuticals files automatic mixed securities shelf
Oct 31 REGN Eylea headwinds said to be behind Regeneron’s post-Q3 plunge
Oct 31 REGN Why Is Regeneron Pharmaceuticals Stock Trading Lower Today?
Oct 31 REGN Regeneron Pharmaceuticals, Inc. (REGN) Q3 2024 Earnings Call Transcript
Oct 31 REGN Regeneron down 10% despite top and bottom line beats
Oct 31 REGN Regeneron Takes A Ghastly Turn As High-Dose Eylea Lags And Biosimilars Loom
Oct 31 REGN Regeneron (REGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Oct 31 REGN REGN Q3 Earnings and Revenues Beat on Strong Eylea HD & Dupixent Sales
Oct 31 OVID Ovid Therapeutics to Host Investor Event
Oct 31 REGN Regeneron (REGN) Tops Q3 Earnings and Revenue Estimates
Oct 31 REGN Regeneron beats results estimates on demand for eczema treatment, eye drug
Oct 31 REGN Regeneron: Q3 Earnings Snapshot
Oct 31 REGN Regeneron Pharmaceuticals Non-GAAP EPS of $12.46 beats by $0.75, revenue of $3.72B beats by $50M
Syndromes

A syndrome is a set of medical signs and symptoms that are correlated with each other and, often, with a particular disease or disorder. The word derives from the Greek σύνδρομον, meaning "concurrence". In some instances, a syndrome is so closely linked with a pathogenesis or cause that the words syndrome, disease, and disorder end up being used interchangeably for them. This is especially true of inherited syndromes. For example, Down syndrome, Wolf–Hirschhorn syndrome, and Andersen syndrome are disorders with known pathogeneses, so each is more than just a set of signs and symptoms, despite the syndrome nomenclature. In other instances, a syndrome is not specific to only one disease. For example, toxic shock syndrome can be caused by various toxins; premotor syndrome can be caused by various brain lesions; and premenstrual syndrome is not a disease but simply a set of symptoms.
If an underlying genetic cause is suspected but not known, a condition may be referred to as a genetic association (often just "association" in context). By definition, an association indicates that the collection of signs and symptoms occurs in combination more frequently than would be likely by chance alone.Syndromes are often named after the physician or group of physicians that discovered them or initially described the full clinical picture. Such eponymous syndrome names are examples of medical eponyms. Recently, there has been a shift towards naming conditions descriptively (by symptoms or underlying cause) rather than eponymously, but the eponymous syndrome names often persist in common usage.

Browse All Tags